Leucovorin
Links shared publicly online about this topic
Oncology Article | Leucovorin Radiation Rectal Neoplasms
mdlinx.com — “Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer” View full resource at mdlinx.com
Most Recently Shared on March 17, 2011 at 6:49 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin fo... http://bit.ly/eKVYXH #oncology
Leucovorin Shortage Hampers Chemo for Colorectal Cancer - Health Blog - WSJ
feeds.wsjonline.com — “Some patients are being forced to go without leucovorin, an generic drug often used to treat colon cancer.” View full resource at feeds.wsjonline.com
Most Recently Shared on December 17, 2008 at 1:16 pm By:
Leucovorin Shortage Hampers Chemo for Colorectal Cancer http://bit.ly/86WH
Oncolytics Biotech® Inc. Announces Opening Of Enrollment In U.S. Phase I Colorectal Cancer Study
medicalnewstoday.com — “Oncolytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ: ONCY) announced that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + I” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2011 at 3:05 pm By:
MNT Colorectal Canc Health News
Oncolytics Biotech® Inc. Announces Opening Of Enrollment In U.S. Phase I Colorectal Cancer Study http://mnt.to/3PR9 #colorectalcancer
Roche drug keeps patients cancer-free longer | Reuters
reuters.com — “ZURICH (Reuters) - Roche's cancer drug Xeloda enabled elderly patients being treated for colorectal cancer to live free of the disease for longer, the world's largest maker of cancer drugs said on Thursday. A” View full resource at reuters.com
Most Recently Shared on January 21, 2010 at 8:34 am By:
HealthIT Policy Health News and Health IT
Roche drug keeps patients cancer-free longer: ZURICH (Reuters) - Roche's cancer drug Xeloda enabled elderly patien... http://bit.ly/648Mtn
Pancreatic Cancer: Will Incremental Advances Begin To Make a Difference? --" J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Pancreatic Cancer: Will Incremental Advances Begin To Make a Difference? --" J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on December 10, 2010 at 3:04 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
5-fluorouracil seen as just as effective as gemcitabine, "gold standard" for pancreatic cancer. See news article... http://fb.me/MgLiWyGA
Pancreatic cancer: drug cocktail improves survival - latimes.com
latimes.com — “A cocktail of four chemotherapy drugs improves survival with pancreatic cancer. Drugs include oxaliplatin, irinotecan, leucovorin and fluorouracil” View full resource at latimes.com
Most Recently Shared on May 12, 2011 at 2:48 am By:
Drugs and Devices OW OW Health
Cocktail of chemotherapy drugs improves survival with pancreatic cancer: A cocktail of four chemotherapy drugs i... http://lat.ms/l1RB7b
Internal Medicine Article | Colonic Neoplasms
mdlinx.com — “A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study” View full resource at mdlinx.com
Most Recently Shared on February 8, 2011 at 9:34 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil ver... http://bit.ly/eFYiFg #medicine
Oncology Article | Breast Neoplasms
mdlinx.com — “Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients” View full resource at mdlinx.com
Most Recently Shared on February 28, 2011 at 3:24 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic brea... http://bit.ly/i7FLPb #oncology
Oncology Article | Pancreas Adenocarcinoma
mdlinx.com — “5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma” View full resource at mdlinx.com
Most Recently Shared on August 22, 2011 at 4:59 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemoth... http://t.co/SWey4Hx #oncology
Oncology Article | Carcinoma, Hepatocellular Chemotherapy, Adjuvant Liver Transplantation
mdlinx.com — “Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: A preliminary open-label study” View full resource at mdlinx.com
Most Recently Shared on August 8, 2011 at 11:46 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transpla... http://bit.ly/nAhfZ4 #oncology
Gastroenterology Article | colorectal cancer
mdlinx.com — “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” View full resource at mdlinx.com
Most Recently Shared on June 15, 2011 at 7:23 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced ... http://bit.ly/jXCOoi #GI
Gastro Medical News about Gastric cancer
mdlinx.com — “S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach” View full resource at mdlinx.com
Most Recently Shared on April 22, 2010 at 7:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectabl... http://bit.ly/cciGoU #GI
Oncology Medical News about Gastric cancer
mdlinx.com — “S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach” View full resource at mdlinx.com
Most Recently Shared on April 23, 2010 at 11:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unres... http://bit.ly/d5Ihro #oncology
Gastro Medical News about Gastrointestinal Neoplasms
mdlinx.com — “Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Palliative Chemotherapy” View full resource at mdlinx.com
Most Recently Shared on June 1, 2010 at 1:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Pallia... http://bit.ly/cPbL07 #GI
Gastroenterology Article | Pancreas Adenocarcinoma
mdlinx.com — “5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma” View full resource at mdlinx.com
Most Recently Shared on August 20, 2011 at 6:11 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy ... http://t.co/VZ9OxKc #GI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
WSJ Health Blog
The WSJ Health Blog offers insight and analysis on health and health biz.
-
MNT Colorectal Canc
The latest colorectal cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
